Pfizer
New York, NY, USA
ROLE SUMMARY The U.S. Vaccines business unit is a critical strategic pillar of Pfizer’s commercial portfolio, representing the largest collective impact on population health and a substantial contribution to enterprise revenues and earnings. Our Vaccines protect millions of lives every year across every stage of life. Our inline and pipeline products represent a key part of Pfizer’s renewed strategy for 2030 and beyond . ABRYSVO, our Respiratory Syncytial Virus (RSV) Vaccine , is a critical pillar of our portfolio, indicated for active immunization ( i ) of pregnant individuals at 32 through 36 weeks gestational age for the prevention of lower respiratory tract disease (LRTD) and sever e LRTD caused by RSV in infants from birth through 6 months of age, as well as (ii) for the prevention of LRTD caused by RSV in individuals 60 years of age and older and (iii) for the prevention...